Pictet Asset Management Sa Abb Vie Inc. Call Options Transaction History

Pictet Asset Management Sa

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 10, 2023	BUY	$144.61 - $166.54 $15.1 Million - $17.3 Million	104,100 New	104,100 $16.6 Million
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $24.1 Million - $29.9 Million	-182,800 Reduced 19.02%	778,100 $126 Million
Q4 2021 Feb 10, 2022	BUY	$107.43 - $135.93 $103 Million - $131 Million	960,900 New	960,900 $130 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Pictet Asset Management Sa, based on Form 13F filings with the SEC.

Stay updated on Pictet Asset Management Sa with notifications on news.